MET and cancer: Several well-known oncogenic pathways have been implicated in the pathogenesis of cancers, including the epidermal growth factor receptor (EGFR), hepatocyte growth factor receptor (HGF/c-Met), and vascular endothelial growth factor (VEGF) pathways [11-15].